Beyond human GBM, Axl is also overexpressed in various haematological and solid cancers, including lung, breast, prostate, and ovarian cancers [58, 59], thus raising the possibility of employing Axl-mediated ZIKV-LAV infection as a therapeutic option against these patient groups. The gene discussed is AXL; the disease is glioblastoma.